Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet Read more
European Commission approves Roche’s Gavreto to treat adults with RET fusion-positive advanced non-small cell lung cancer Read more
FDA approves Roche’s Susvimo for neovascular or “wet” age-related macular degeneration (nAMD) Read more